Literature DB >> 21659519

Role of putative second transmembrane region of Nox2 protein in the structural stability and electron transfer of the phagocytic NADPH oxidase.

Antoine Picciocchi1, Franck Debeurme, Sylvain Beaumel, Marie-Claire Dagher, Didier Grunwald, Algirdas J Jesaitis, Marie-José Stasia.   

Abstract

Flavocytochrome b(558) (cytb) of phagocytes is a heterodimeric integral membrane protein composed of two subunits, p22(phox) and gp91(phox). The latter subunit, also known as Nox2, has a cytosolic C-terminal "dehydrogenase domain" containing FAD/NADPH-binding sites. The N-terminal half of Nox2 contains six predicted transmembrane α-helices coordinating two hemes. We studied the role of the second transmembrane α-helix, which contains a "hot spot" for mutations found in rare X(+) and X(-) chronic granulomatous disease. By site-directed mutagenesis and transfection in X-CGD PLB-985 cells, we examined the functional and structural impact of seven missense mutations affecting five residues. P56L and C59F mutations drastically influence the level of Nox2 expression indicating that these residues are important for the structural stability of Nox2. A53D, R54G, R54M, and R54S mutations do not affect spectral properties of oxidized/reduced cytb, oxidase complex assembly, FAD binding, nor iodonitrotetrazolium (INT) reductase (diaphorase) activity but inhibit superoxide production. This suggests that Ala-53 and Arg-54 are essential in control of electron transfer from FAD. Surprisingly, the A57E mutation partially inhibits FAD binding, diaphorase activity, and oxidase assembly and affects the affinity of immunopurified A57E cytochrome b(558) for p67(phox). By competition experiments, we demonstrated that the second transmembrane helix impacts on the function of the first intracytosolic B-loop in the control of diaphorase activity of Nox2. Finally, by comparing INT reductase activity of immunopurified mutated and wild type cytb under aerobiosis versus anaerobiosis, we showed that INT reduction reflects the electron transfer from NADPH to FAD only in the absence of superoxide production.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21659519      PMCID: PMC3151079          DOI: 10.1074/jbc.M111.220418

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Analysis of glycosylation sites on gp91phox, the flavocytochrome of the NADPH oxidase, by site-directed mutagenesis and translation in vitro.

Authors:  T M Wallach; A W Segal
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

2.  Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly.

Authors:  Xing Jun Li; Franck Fieschi; Marie-Hélène Paclet; Didier Grunwald; Yannick Campion; Philippe Gaudin; Françoise Morel; Marie-José Stasia
Journal:  J Leukoc Biol       Date:  2006-10-23       Impact factor: 4.962

3.  Evaluation of two anti-gp91phox antibodies as immunoprobes for Nox family proteins: mAb 54.1 recognizes recombinant full-length Nox2, Nox3 and the C-terminal domains of Nox1-4 and cross-reacts with GRP 58.

Authors:  Danas Baniulis; Yoko Nakano; William M Nauseef; Botond Banfi; Guangjie Cheng; David J Lambeth; James B Burritt; Ross M Taylor; Algirdas J Jesaitis
Journal:  Biochim Biophys Acta       Date:  2005-09-25

4.  Mutagenesis of an arginine- and lysine-rich domain in the gp91(phox) subunit of the phagocyte NADPH-oxidase flavocytochrome b558.

Authors:  K J Biberstine-Kinkade; L Yu; M C Dinauer
Journal:  J Biol Chem       Date:  1999-04-09       Impact factor: 5.157

5.  NADPH dehydrogenase activity of p67PHOX, a cytosolic subunit of the leukocyte NADPH oxidase.

Authors:  P M Dang; B M Babior; R M Smith
Journal:  Biochemistry       Date:  1999-05-04       Impact factor: 3.162

6.  Crucial role of two potential cytosolic regions of Nox2, 191TSSTKTIRRS200 and 484DESQANHFAVHHDEEKD500, on NADPH oxidase activation.

Authors:  Xing Jun Li; Didier Grunwald; Jacques Mathieu; Françoise Morel; Marie-José Stasia
Journal:  J Biol Chem       Date:  2005-01-31       Impact factor: 5.157

7.  Probing the role of the carboxyl terminus of the gp91phox subunit of neutrophil flavocytochrome b558 using site-directed mutagenesis.

Authors:  L Zhen; L Yu; M C Dinauer
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

Review 8.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.

Authors:  Karen Bedard; Karl-Heinz Krause
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

9.  Role of histidines identified by mutagenesis in the NADPH oxidase-associated H+ channel.

Authors:  L M Henderson
Journal:  J Biol Chem       Date:  1998-12-11       Impact factor: 5.157

10.  Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes.

Authors:  Tsukasa Kawahara; Mark T Quinn; J David Lambeth
Journal:  BMC Evol Biol       Date:  2007-07-06       Impact factor: 3.260

View more
  11 in total

1.  Constitutive NADPH oxidase 4 activity resides in the composition of the B-loop and the penultimate C terminus.

Authors:  Katharina von Löhneysen; Deborah Noack; Patti Hayes; Jeffrey S Friedman; Ulla G Knaus
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

2.  Down-regulation of NOX2 activity in phagocytes mediated by ATM-kinase dependent phosphorylation.

Authors:  Sylvain Beaumel; Antoine Picciocchi; Franck Debeurme; Corinne Vivès; Anne-Marie Hesse; Myriam Ferro; Didier Grunwald; Heather Stieglitz; Pahk Thepchatri; Susan M E Smith; Franck Fieschi; Marie José Stasia
Journal:  Free Radic Biol Med       Date:  2017-09-13       Impact factor: 7.376

3.  Crystal structures and atomic model of NADPH oxidase.

Authors:  Francesca Magnani; Simone Nenci; Elisa Millana Fananas; Marta Ceccon; Elvira Romero; Marco W Fraaije; Andrea Mattevi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

4.  Variant Type X91+ Chronic Granulomatous Disease: Clinical and Molecular Characterization in a Chinese Cohort.

Authors:  Bijun Sun; Zeyu Zhu; Xiaoying Hui; Jinqiao Sun; Wenjie Wang; Wenjing Ying; Qinhua Zhou; Haili Yao; Jia Hou; Xiaochuan Wang
Journal:  J Clin Immunol       Date:  2022-07-07       Impact factor: 8.317

5.  Clinical, functional and genetic analysis of twenty-four patients with chronic granulomatous disease - identification of eight novel mutations in CYBB and NCF2 genes.

Authors:  Cécile Martel; Michelle Mollin; Sylvain Beaumel; Jean Paul Brion; Charles Coutton; Véronique Satre; Gaëlle Vieville; Mary Callanan; Christine Lefebvre; Alexandra Salmon; Anne Pagnier; Dominique Plantaz; Cécile Bost-Bru; Laurence Eitenschenck; Isabelle Durieu; Daniel Floret; Claire Galambrun; Hervé Chambost; Gérard Michel; Jean-Louis Stephan; Olivier Hermine; Stéphane Blanche; Nathalie Blot; Hervé Rubié; Guillaume Pouessel; Stephanie Drillon-Haus; Bernard Conrad; Klara M Posfay-Barbe; Zuzana Havlicekova; Tamara Voskresenky-Baricic; Kelecic Jadranka; Maria Cristina Arriazu; Luis Alberto Garcia; Lamia Sfaihi; Lamia Sfaihi Ben Mansour; Pierre Bordigoni; Marie José Stasia
Journal:  J Clin Immunol       Date:  2012-05-05       Impact factor: 8.317

Review 6.  The basic biology of redoxosomes in cytokine-mediated signal transduction and implications for disease-specific therapies.

Authors:  Netanya Y Spencer; John F Engelhardt
Journal:  Biochemistry       Date:  2014-03-04       Impact factor: 3.162

7.  Optimized Generation of Functional Neutrophils and Macrophages from Patient-Specific Induced Pluripotent Stem Cells: Ex Vivo Models of X(0)-Linked, AR22(0)- and AR47(0)- Chronic Granulomatous Diseases.

Authors:  Julie Brault; Erwan Goutagny; Narasimha Telugu; Kaifeng Shao; Mathurin Baquié; Véronique Satre; Charles Coutton; Didier Grunwald; Jean-Paul Brion; Vincent Barlogis; Jean-Louis Stephan; Dominique Plantaz; Jürgen Hescheler; Karl-Heinz Krause; Tomo Sarić; Marie José Stasia
Journal:  Biores Open Access       Date:  2014-12-01

8.  Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.

Authors:  Julie Brault; Guillaume Vaganay; Aline Le Roy; Jean-Luc Lenormand; Sandra Cortes; Marie José Stasia
Journal:  Int J Nanomedicine       Date:  2017-03-20

9.  Clinical, functional and genetic characterization of 16 patients suffering from chronic granulomatous disease variants - identification of 11 novel mutations in CYBB.

Authors:  M Mollin; S Beaumel; B Vigne; J Brault; N Roux-Buisson; J Rendu; V Barlogis; G Catho; C Dumeril; F Fouyssac; D Monnier; V Gandemer; M Revest; J-P Brion; C Bost-Bru; E Jeziorski; L Eitenschenck; C Jarrasse; S Drillon Haus; M Houachée-Chardin; M Hancart; G Michel; Y Bertrand; D Plantaz; J Kelecic; R Traberg; L Kainulainen; J Fauré; F Fieschi; M J Stasia
Journal:  Clin Exp Immunol       Date:  2020-10-12       Impact factor: 4.330

Review 10.  Genetic disorders coupled to ROS deficiency.

Authors:  Sharon O'Neill; Julie Brault; Marie-Jose Stasia; Ulla G Knaus
Journal:  Redox Biol       Date:  2015-07-17       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.